How Slow RNA Polymerase II Elongation Favors Alternative Exon Skipping

Molecular Cell

Volumn 54, Issue 4, 2014, Pages 683-690

  Dujardin, Gwendal ^a,b   Lafaille, Celina ^a   de la Mata, Manuel ^a   Marasco, Luciano E ^a   Muñoz, Manuel J ^a   Le Jossic Corcos, Catherine ^b   Corcos, Laurent ^b   Kornblihtt, Alberto R ^a  

^a INSTITUTO DE FISIOLOGÍA   (Argentina)

^b FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RNA POLYMERASE II;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; AMPLICON; ARTICLE; CACO 2 CELL LINE; CHROMATIN STRUCTURE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXON; EXON SKIPPING; EXPRESSION VECTOR; HUMAN; HUMAN CELL; POINT MUTATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION ELONGATION; ULTRAVIOLET IRRADIATION; WESTERN BLOTTING;

ALTERNATIVE SPLICING; BINDING SITES; CACO-2 CELLS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EXONS; HEK293 CELLS; HUMANS; MODELS, GENETIC; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; RIBONUCLEOPROTEINS; RNA POLYMERASE II; RNA SPLICE SITES; RNA-BINDING PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84901188097     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2014.03.044     Document Type: Article

References (40)

1. Alló M., Buggiano V., Fededa J.P., Petrillo E., Schor I., de la Mata M., Agirre E., Plass M., Eyras E., Elela S.A., et al. Control of alternative splicing through siRNA-mediated transcriptional gene silencing. Nat. Struct. Mol. Biol. 2009, 16:717-724.
2. Ameyar-Zazoua M., Rachez C., Souidi M., Robin P., Fritsch L., Young R., Morozova N., Fenouil R., Descostes N., Andrau J.C., et al. Argonaute proteins couple chromatin silencing to alternative splicing. Nat. Struct. Mol. Biol. 2012, 19:998-1004.
3. Blau J., Xiao H., McCracken S., O'Hare P., Greenblatt J., Bentley D. Three functional classes of transcriptional activation domain. Mol. Cell. Biol. 1996, 16:2044-2055.
4. Boireau S., Maiuri P., Basyuk E., de la Mata M., Knezevich A., Pradet-Balade B., Bäcker V., Kornblihtt A., Marcello A., Bertrand E. The transcriptional cycle of HIV-1 in real-time and live cells. J. Cell Biol. 2007, 179:291-304.
5. Buratti E., Dörk T., Zuccato E., Pagani F., Romano M., Baralle F.E. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J. 2001, 20:1774-1784.
6. Chu C.S., Trapnell B.C., Murtagh J.J., Moss J., Dalemans W., Jallat S., Mercenier A., Pavirani A., Lecocq J.P., Cutting G.R., et al. Variable deletion of exon 9 coding sequences in cystic fibrosis transmembrane conductance regulator gene mRNA transcripts in normal bronchial epithelium. EMBO J. 1991, 10:1355-1363.
7. Close P., East P., Dirac-Svejstrup A.B., Hartmann H., Heron M., Maslen S., Chariot A., Söding J., Skehel M., Svejstrup J.Q. DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. Nature 2012, 484:386-389.
8. Danko C.G., Hah N., Luo X., Martins A.L., Core L., Lis J.T., Siepel A., Kraus W.L. Signaling pathways differentially affect RNA polymerase II initiation, pausing, and elongation rate in cells. Mol. Cell 2013, 50:212-222.
9. Darnell J.E. Reflections on the history of pre-mRNA processing and highlights of current knowledge: a unified picture. RNA 2013, 19:443-460.
10. Darzacq X., Shav-Tal Y., de Turris V., Brody Y., Shenoy S.M., Phair R.D., Singer R.H. In vivo dynamics of RNA polymerase II transcription. Nat. Struct. Mol. Biol. 2007, 14:796-806.
11. Das R., Yu J., Zhang Z., Gygi M.P., Krainer A.R., Gygi S.P., Reed R. SR proteins function in coupling RNAP II transcription to pre-mRNA splicing. Mol. Cell 2007, 26:867-881.
12. David C.J., Manley J.L. Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev. 2010, 24:2343-2364.
13. de la Mata M., Kornblihtt A.R. RNA polymerase II C-terminal domain mediates regulation of alternative splicing by SRp20. Nat. Struct. Mol. Biol. 2006, 13:973-980.
14. de la Mata M., Alonso C.R., Kadener S., Fededa J.P., Blaustein M., Pelisch F., Cramer P., Bentley D., Kornblihtt A.R. A slow RNA polymerase II affects alternative splicing in vivo. Mol. Cell 2003, 12:525-532.
15. Dujardin G., Buratti E., Charlet-Berguerand N., Martins de Araujo M., Mbopda A., Le Jossic-Corcos C., Pagani F., Ferec C., Corcos L. CELF proteins regulate CFTR pre-mRNA splicing: essential role of the divergent domain of ETR-3. Nucleic Acids Res. 2010, 38:7273-7285.
16. Dutertre M., Sanchez G., De Cian M.C., Barbier J., Dardenne E., Gratadou L., Dujardin G., Le Jossic-Corcos C., Corcos L., Auboeuf D. Cotranscriptional exon skipping in the genotoxic stress response. Nat. Struct. Mol. Biol. 2010, 17:1358-1366.
17. Howe K.J., Kane C.M., Ares M. Perturbation of transcription elongation influences the fidelity of internal exon inclusion in Saccharomyces cerevisiae. RNA 2003, 9:993-1006.
18. Huang Y., Li W., Yao X., Lin Q.J., Yin J.W., Liang Y., Heiner M., Tian B., Hui J., Wang G. Mediator complex regulates alternative mRNA processing via the MED23 subunit. Mol. Cell 2012, 45:459-469.
19. Ip J.Y., Schmidt D., Pan Q., Ramani A.K., Fraser A.G., Odom D.T., Blencowe B.J. Global impact of RNA polymerase II elongation inhibition on alternative splicing regulation. Genome Res. 2011, 21:390-401.
20. Kadener S., Cramer P., Nogués G., Cazalla D., de la Mata M., Fededa J.P., Werbajh S.E., Srebrow A., Kornblihtt A.R. Antagonistic effects of T-Ag and VP16 reveal a role for RNA pol II elongation on alternative splicing. EMBO J. 2001, 20:5759-5768.
21. König J., Zarnack K., Rot G., Curk T., Kayikci M., Zupan B., Turner D.J., Luscombe N.M., Ule J. iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution. Nat. Struct. Mol. Biol. 2010, 17:909-915.
22. Kornblihtt A.R., Schor I.E., Alló M., Dujardin G., Petrillo E., Muñoz M.J. Alternative splicing: a pivotal step between eukaryotic transcription and translation. Nat. Rev. Mol. Cell Biol. 2013, 14:153-165.
23. Listerman I., Sapra A.K., Neugebauer K.M. Cotranscriptional coupling of splicing factor recruitment and precursor messenger RNA splicing in mammalian cells. Nat. Struct. Mol. Biol. 2006, 13:815-822.
24. Luco R.F., Pan Q., Tominaga K., Blencowe B.J., Pereira-Smith O.M., Misteli T. Regulation of alternative splicing by histone modifications. Science 2010, 327:996-1000.
25. Luco R.F., Alló M., Schor I.E., Kornblihtt A.R., Misteli T. Epigenetics in alternative pre-mRNA splicing. Cell 2011, 144:16-26.
26. Monsalve M., Wu Z., Adelmant G., Puigserver P., Fan M., Spiegelman B.M. Direct coupling of transcription and mRNA processing through the thermogenic coactivator PGC-1. Mol. Cell 2000, 6:307-316.
27. Muñoz M.J., Pérez Santangelo M.S., Paronetto M.P., de la Mata M., Pelisch F., Boireau S., Glover-Cutter K., Ben-Dov C., Blaustein M., Lozano J.J., et al. DNA damage regulates alternative splicing through inhibition of RNA polymerase II elongation. Cell 2009, 137:708-720.
28. Nogués G., Kadener S., Cramer P., Bentley D., Kornblihtt A.R. Transcriptional activators differ in their abilities to control alternative splicing. J. Biol. Chem. 2002, 277:43110-43114.
29. Pagani F., Buratti E., Stuani C., Romano M., Zuccato E., Niksic M., Giglio L., Faraguna D., Baralle F.E. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element. J. Biol. Chem. 2000, 275:21041-21047.
30. Roberts G.C., Gooding C., Mak H.Y., Proudfoot N.J., Smith C.W. Co-transcriptional commitment to alternative splice site selection. Nucleic Acids Res. 1998, 26:5568-5572.
31. Schmidt U., Basyuk E., Robert M.C., Yoshida M., Villemin J.P., Auboeuf D., Aitken S., Bertrand E. Real-time imaging of cotranscriptional splicing reveals a kinetic model that reduces noise: implications for alternative splicing regulation. J. Cell Biol. 2011, 193:819-829.
32. Schor I.E., Rascovan N., Pelisch F., Alló M., Kornblihtt A.R. Neuronal cell depolarization induces intragenic chromatin modifications affecting NCAM alternative splicing. Proc. Natl. Acad. Sci. USA 2009, 106:4325-4330.
33. Schor I.E., Fiszbein A., Petrillo E., Kornblihtt A.R. Intragenic epigenetic changes modulate NCAM alternative splicing in neuronal differentiation. EMBO J. 2013, 32:2264-2274.
34. Shukla S., Kavak E., Gregory M., Imashimizu M., Shutinoski B., Kashlev M., Oberdoerffer P., Sandberg R., Oberdoerffer S. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature 2011, 479:74-79.
35. Singh R.K., Cooper T.A. Pre-mRNA splicing in disease and therapeutics. Trends Mol. Med. 2012, 18:472-482.
36. Singh J., Padgett R.A. Rates of in situ transcription and splicing in large human genes. Nat. Struct. Mol. Biol. 2009, 16:1128-1133.
37. Solier S., Barb J., Zeeberg B.R., Varma S., Ryan M.C., Kohn K.W., Weinstein J.N., Munson P.J., Pommier Y. Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors. Cancer Res. 2010, 70:8055-8065.
38. Sordet O., Larochelle S., Nicolas E., Stevens E.V., Zhang C., Shokat K.M., Fisher R.P., Pommier Y. Hyperphosphorylation of RNA polymerase II in response to topoisomerase I cleavage complexes and its association with transcription- and BRCA1-dependent degradation of topoisomerase I. J. Mol. Biol. 2008, 381:540-549.
39. Tilgner H., Knowles D.G., Johnson R., Davis C.A., Chakrabortty S., Djebali S., Curado J., Snyder M., Gingeras T.R., Guigó R. Deep sequencing of subcellular RNA fractions shows splicing to be predominantly co-transcriptional in the human genome but inefficient for lncRNAs. Genome Res. 2012, 22:1616-1625.
40. Zuccato E., Buratti E., Stuani C., Baralle F.E., Pagani F. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing. J. Biol. Chem. 2004, 279:16980-16988.